Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 280

    2.

    Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.

    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.

    Diabetes Care. 1995 Aug;18(8):1113-23.PMID: 7587846 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.

    Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N.

    Diabetes Care. 1996 Dec;19(12):1375-81.PMID: 8941467 [PubMed - indexed for MEDLINE]Related articles

    4.

    Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

    Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK.

    Diabetes Care. 1998 Apr;21(4):574-9.PMID: 9571345 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

    Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS.

    Arch Intern Med. 1997 Jan 27;157(2):181-8.PMID: 9009975 [PubMed - indexed for MEDLINE]Related articles

    6.

    Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM).

    Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FQ, Comstock JP, Colwell JA.

    Diabetes Care. 1998 Apr;21(4):510-5.PMID: 9571333 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    8.

    Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.

    Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W; VA Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

    J Diabetes Complications. 2003 Nov-Dec;17(6):314-22.PMID: 14583175 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.

    Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS.

    Arch Intern Med. 1998 Dec 7-21;158(22):2485-90.PMID: 9855387 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Health-related quality of life in the VA Feasibility Study on glycemic control and complications in type 2 diabetes mellitus.

    Pitale S, Kernan-Schroeder D, Emanuele N, Sawin C, Sacks J, Abraira C; VACSDM Study Group.

    J Diabetes Complications. 2005 Jul-Aug;19(4):207-11.PMID: 15993354 [PubMed - indexed for MEDLINE]Related articles

    16.

    Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.

    Genuth S.

    Ann Intern Med. 1996 Jan 1;124(1 Pt 2):104-9.PMID: 8554200 [PubMed - indexed for MEDLINE]Related articles

    17.

    Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.

    Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman SV, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA.

    JAMA. 1996 Oct 23-30;276(16):1322-7.PMID: 8861991 [PubMed - indexed for MEDLINE]Related articles

    18.

    Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

    Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

    Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Conversion from low-dose insulin therapy to glipizide in patients with non-insulin-dependent diabetes mellitus.

    Rosenstock J, Meisel A, Raskin P.

    Am J Med. 1987 Sep 18;83(3A):10-5.PMID: 3307402 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data